1. AB0478 Systematic safety review of five biologic antirheumatic drugs. (23rd January 2014) Authors: Stuart, M.E.; Shrite, S.A.; Gandra, S.R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0496 Tumor necrosis factor (TNF)-inhibitor dose escalation in rheumatoid arthritis (RA) patients in a united states (US) pharmacy benefits management (PBM) setting. (23rd January 2014) Authors: Blume, S.W.; Fox, K.M.; Joseph, G.; Chuang, C.-C.; Thomas, J.; Gandra, S.R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0499 Post-discontinuation treatment patterns for tumor necrosis factor-blockers in rheumatoid arthritis patients in the US. (23rd January 2014) Authors: Schabert, V.F.; Fox, K.M.; Watson, C.; Yeaw, J.; Goodman, S.; Gandra, S.R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification and management of canadian patients with symptoms of statin intolerance: Results from a real-world clinical practice survey. (September 2016) Authors: Oh, P.; Hovingh, G.K.; Gandra, S.R.; McKendrick, J.; Dent, R.; Wieffer, H.M.; Catapano, A.L.; Rosenson, R.S.; Stroes, E.S.G. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Patient‐reported outcomes in moderate‐to‐severe plaque psoriasis with scalp involvement: results from a randomized, double‐blind, placebo‐controlled study of etanercept. (21st December 2011) Authors: Tyring, S.; Bagel, J.; Lynde, C.; Klekotka, P.; Thompson, E.H.Z.; Gandra, S.R.; Shi, Y.; Kricorian, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 27:Number 1(2013:Jan.) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0143 Tumor necrosis factor-blocker use in us managed care: Utilization and dosing patterns among rheumatoid arthritis patients. (23rd January 2014) Authors: Fisher, M.; Watson, C.; Fox, K.M.; Chen, Y.-W.; Gandra, S.R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The efficacy of evolocumab and other lipid-lowering therapies (LLT) for the management of low density lipoprotein cholesterol (LDL-C): a systematic review and network meta-analysis (NMA). (September 2016) Authors: Worthy, G.; Gandra, S.R.; Bridges, I.; Worth, G.; Dent, R.; Cheng, L.I.; Forbes, C.; Deshpande, S.; Ross, J.; Kleijnen, J.; Stroes, E.S.G. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗